Blood Coagulation and Coagulation Tests

Alkjaersig, 1959, The mechanism of clot dissolution by plasma, J. Clin. Invest, 38, 1086, 10.1172/JCI103885 Astrup, 1966, Tissue activators of plasminogen, Fed. Proc, 25, 41 Bell, 1982, Defibrinogenating enzymes Bloom, 1980, The von Willebrand syndrome, Semin. Hematol, 17, 215 Broekmans, 1983, Cogenital protein C deficiency and venous thromboembolism, N. Engl. J. Med, 309, 340, 10.1056/NEJM198308113090604 Carvalho, 1974, A comparison of the staphylococcal clumping test and an agglutination test for detection of fibrinogen degradation products, Am. J. Clin. Pathol, 62, 107, 10.1093/ajcp/62.1.107 Colman, 1975, Williams trait: Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associ-ated with abnormalities of the Hageman factor-dependent pathways, J. Clin. Invest, 56, 1650, 10.1172/JCI108247 Colman, 1979, Disseminated intravascular coagulation:A reappraisal, Annu. Rev. Med, 30, 359, 10.1146/annurev.me.30.020179.002043 Comp, 1982, Activation of protein C in vivo, J. Clin. Invest, 70, 127, 10.1172/JCI110584 Crabtree, 1981, Molecular cloning of cDNA for the a, (3, and 7 chains of rat fibrinogen, J. Biol. Chem, 256, 9718, 10.1016/S0021-9258(19)68822-8 Crabtree, 1982, Coordinate accumulation of the mRNAs for the α β and γ chains of rat fibrinogen following defibrination, J. Biol. Chem, 257, 7277, 10.1016/S0021-9258(18)34368-0 Davidson, 1981, Assessment of the fibrinolytic system Doolittle, 1973, Structural aspects of the fibrinogen to fibrin conversion, Adv. Protein Chem, 27, 1, 10.1016/S0065-3233(08)60446-5 Doolittle, 1981, Fibrinogen and fibrin Esmon, 1983, Protein C: Biochemistry, physiology and clinical applications, Blood, 62, 1155, 10.1182/blood.V62.6.1155.1155 Esmon, 1975, The functional significance of vitamin K action, J. Biol. Chem, 250, 4095, 10.1016/S0021-9258(19)41391-4 Fowler, 1980, Electron microscopy of plasmic fragments of human fibrinogen as related to the trinodular structure of the intact mol-ecule, J. Clin. Invest, 66, 50, 10.1172/JCI109834 Francis, 1983, Mechanisms of fibrinolysis Fulcher, 1982, Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody, Proc. Natl. Acad. Sci. USA, 79, 1648, 10.1073/pnas.79.5.1648 Gaarder, 1961, Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets, Nature, 192, 531, 10.1038/192531a0 Gaffney, 1975, Characterization of a soluble D-dimer-E complex in crosslinked fibrin digests, Thromb. Res, 7, 89, 10.1016/0049-3848(75)90127-9 Gallop, 1980, Carboxylated calcium-binding proteins and vitamin K, N. Engl. J. Med, 302, 1460, 10.1056/NEJM198006263022608 Goodnough, 1983, Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: A report of 21 patients and a review of 50 previously reported cases, Medicine, 62, 248, 10.1097/00005792-198307000-00004 Graham, 1979, Genotype assignment (carrier detection) in the hemophilias, Clin. Hae matol, 8, 115, 10.1016/S0308-2261(21)00066-7 Griffin, 1981, Deficiency of protein C in congenital thrombotic disease, J. Clin. Invest, 68, 1370, 10.1172/JCI110385 Harker, 1972, The bleeding time as a screening test or platelet function, N. Engl. J. Med, 287, 155, 10.1056/NEJM197207272870401 Harker, 1972, Platelet and fibrinogen consumption in man, N. Engl. J. Med, 287, 999, 10.1056/NEJM197211162872001 Hathaway, 1965, Evidence of a new plasma coagulation factor I: Case report, coagulation studies and physiochemical properties, Br. J. Haematol, 26, 521 Heimark, 1980, Surface activation of blood coagulation, fibrinolysis, and kinin formation, Nature, 286, 456, 10.1038/286456a0 Holmberg, 1981, Assessment of blood coagulation and general haemostasis Howard, 1971, Ristocetin-a new tool in the investigation of platelet aggregation, Thromb. Diath. Haemorrh, 26, 362, 10.1055/s-0038-1653684 Hoyer, 1973, Immunologic properties of antihemophilic factor, Prog. Hematol, 8, 191 Hougie, 1983, Recalcification time test and its modifications (partial thromboplastin time, activated partial thromboplastin time, and expanded partial thromboplastin time) Hougie, 1983, One-stage prothrombin time Hougie, 1983, Methods for estimating fibrinogen concentration Hougie, 1983, Euglobulin lysis time Hultin, 1978, Activation of factor X by factors IXa and VIII: A specific assay for factor IXa in the presence of thrombin-activated factor VIII, Blood, 52, 928, 10.1182/blood.V52.5.928.928 Jackson, 1980, Blood coagulation, Annu. Rev. Biochem, 49, 765, 10.1146/annurev.bi.49.070180.004001 Jaffe, 1983, Vascular function in hemostasis Jaffe, 1974, Synthesis of von Willebrand factor by cultured human endothelial cells, Proc. Natl. Acad. Sci. USA, 72, 1906, 10.1073/pnas.71.5.1906 Kane, 1982, The interaction of human coagulation factor Va with platelets, J. Biol. Chem, 257, 3963, 10.1016/S0021-9258(18)34877-4 Kane, 1980, Factor Va-dependent binding of factor Xa to human platelets, J. Biol. Chem, 255, 1170, 10.1016/S0021-9258(19)86158-6 Kaplan, 1978, Initiation of the intrinsic coagulation and fibrinolytic pathways of man: The role of surfaces, Hageman factor, prekallikrein, high molecular weight kininogen, and Factor XI, Prog. Hemost. Thromb, 4, 127 Kelton, 1980, Bleeding associated with antithrombotic therapy, Semin. Hematol, 17, 259 Kitchens, 1979, Factor XIII, Medicine, 58, 413, 10.1097/00005792-197911000-00002 Leiba, 1965, Heredity and coagulation studies in ten families with factor XI (Plasma thromboplastin antecedent) deficiency, Br. J. Haematol, 11, 654, 10.1111/j.1365-2141.1965.tb00114.x Majerus, 1978, Relationship between platelets and coagulation factors in hemostasis, Annu. Rev. Med, 29, 41, 10.1146/annurev.me.29.020178.000353 Marder, 1975, Data for defining fibrinogen and its plasmic degradation products, Thromb. Diath. Haemorrh, 33, 199, 10.1055/s-0038-1647872 Marder, 1982, Fibrinogen structure and physiology McMillin, 1974, The secondary structure of human Hage-man factor (factor XII) and its alteration by activating agents, J. Clin. Invest, 54, 1312, 10.1172/JCI107877 Moroi, 1976, Isolation of characterization of alpha 2-plasmin inhibitor from human plasma: A novel proteinase inhibitor which inhibits activator-induced clot lysis, J. Biol. Chem, 251, 5956, 10.1016/S0021-9258(17)33045-4 Nachman, 1977, Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes, J. Clin. Invest, 60, 914, 10.1172/JCI108846 Nelsestuen, 1976, Role of 7-carboxyglutamic acid, J. Biol. Chem, 251, 5648, 10.1016/S0021-9258(17)33107-1 Nemerson, 1968, The phospholipid requirement of tissue factor in blood coagulation, J. Clin. Invest, 47, 72, 10.1172/JCI105716 Nemerson, 1983, Regulation of the initiation of coagulation by factor VII, Haemostasis, 13, 150 Nemerson, 1982, Tissue factor revisited, Prog. Hemostas. Thrombos, 6, 237 Nesheim, 1984, "Clotspeed"-a mathematical simulation of the functional properties of prothrombinase, J. Biol. Chem, 259, 1447, 10.1016/S0021-9258(17)43427-2 Olexa, 1980, Evidence for four different polymerization sites involved in human fibrin formation, Proc. Natl. Acad. Sci. USA, 77, 1374, 10.1073/pnas.77.3.1374 Pizzo, 1973, Subunit structure of Fragment D from fibrinogen and cross-linked fibrin, J. Biol. Chem, 248, 4584, 10.1016/S0021-9258(19)43704-6 Ratnoff, 1955, A familial hemorrhagic trait associated with a deficiency of clot-promoting fraction of plasma, J. Clin. Invest, 34, 602, 10.1172/JCI103109 Robbins, 1982, The plasminogen-plasmin enzyme system Robboy, 1970, Circulating anticoagulants to factor VIII, Am. J. Med, 49, 742, 10.1016/S0002-9343(70)80056-0 Rosenberg, 1975, Actions and interactions of antithrombin and heparin, N. Engl. J. Med, 292, 146, 10.1056/NEJM197501162920307 Rosenberg, 1973, The purification and mechanism of action of human antithrombin-heparin cofactor, J. Biol. Chem, 248, 6490, 10.1016/S0021-9258(19)43472-8 Rosenberg, 1977, The neutralization of thrombin and other serine proteases of the hemostatic mechanism Ruggeri, 1980, Variant von Willebrand's disease, J. Clin. Invest, 65, 1318, 10.1172/JCI109795 Saito, 1975, Fitzgerald trait: Deficiency of a hithertounrecognized agent, Fitzgerald factor, participating in surface-mediated reactions of clotting, fibrinolysis, generation of kinins, and the property of diluted plasma enhancing vascular permeability (PF-dil), J. Clin. Invest, 55, 1082, 10.1172/JCI108009 Shapiro, 1975, Acquired inhibitors to the blood coagulation factors, Semin. Hemostas. Thromb, 1, 336 Shapiro, 1982, Lupus anticoagulants, Prog. Hemost. Thromb, 6, 263 Shattil, 1980, Platelets and their membranes in hemostasis: Physiology and pathophysiology, Ann. Intern. Med, 94, 108, 10.7326/0003-4819-94-1-108 Sixma, 1977, The hemostatic plug, Semin. Hematol, 14, 265 Stel, 1983, Detection of factor VIII/coagulant antigen in human liver tissue, Nature, 303, 530, 10.1038/303530a0 Stemerman, 1974, Vascular intimal components: Precursors of thrombosis, Prog. He-most. Thromb, 2, 1 Sentflo, 1977, Vitamin K-dependent formation of 7-carboxyglutamic acid, Annu. Rev. Biochem, 46, 157, 10.1146/annurev.bi.46.070177.001105 Stern, 1983, Binding of factors IX and IXa to cultured vascular endothelial cells, Proc. Natl. Acad. Sci. USA, 80, 4119, 10.1073/pnas.80.13.4119 Switzer, 1977, Effects of thrombin on factor V and factor VIII Suttie, 1980, Mechanism of action of vitamin K: Synthesis of 7-carboxyglutamic acid, CRC Crit. Rev. Biochem, 8, 191, 10.3109/10409238009105469 Takagi, 1975, Amino acid sequence studies on plasmin-derived fragments of human fibrinogen: Amino-terminal sequences of intermediate and terminal fragments, Biochemistry, 14, 940, 10.1021/bi00676a010 Thiagarajan, 1980, Monoclonal immunoglobulin MX coagulation inhibitor with phospholipid specificity, J. Clin. Invest, 66, 397, 10.1172/JCI109869 Travis, 1983, Human plasma proteinase inhibitors, Ann. Rev. Biochem, 52, 655, 10.1146/annurev.bi.52.070183.003255 Tschopp, 1974, Decreased adhesion of platelets to subendothelium in von Willebrand's disease, J. Lab. Clin. Med, 83, 296 Van Mourik, 1974, Factor VIII: A series of homologous oligomers and a complex of two proteins, Thromb. Res, 4, 155, 10.1016/0049-3848(74)90211-4 Verstraete, 1974, Intravascular coagulation in liver disease, Annu. Rev. Med, 25, 447, 10.1146/annurev.me.25.020174.002311 Weiss, 1973, Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation, J. Clin. Invest, 52, 2708, 10.1172/JCI107465 Wessler, 1967, A distinction between the role of precursor and activated forms of clotting factors in the genesis of stasis thrombi, Thromb. Diath. Haemorrh, 18, 12, 10.1055/s-0038-1655013 Wuepper, 1975, Flaujeac trait: Deficiency of human plasma kininogen, J. Clin. Invest, 56, 1663, 10.1172/JCI108248 Zimmerman, 1982, von Willebrand's disease, Prog. Hemost. Thromb, 6, 203 Zimmerman, 1971, Immunologic differentiation of classic hemophilia (factor VIII deficiency and von Willebrand's disease), J. Clin. Invest, 50, 244, 10.1172/JCI106480 Zucker, 1947, Platelet agglutination and vasoconstriction as factors in spontaneous hemostasis in normal, thrombocytopenic, heparinized, and hypoprothrombinemic rats, Am. J. Physiol, 148, 275, 10.1152/ajplegacy.1947.148.2.275 Zur, 1980, Kinetics of factor IX activation via the extrinsic pathway, J. Biol. Chem, 255, 5703, 10.1016/S0021-9258(19)70686-3 Zur, 1982, The dual role of factor VII in blood coagulation, J. Biol. Chem, 257, 5623, 10.1016/S0021-9258(19)83823-1 Zur, 1978, Kinetics of the tissue factor pathway of coagulation: activation of factor IX, Blood, 52, 198